Basilea Pharmaceutica Profile

USD 0.35  0.49%

Basilea Pharmaceutica Summary

Basilea Pharmaceutica AG (BPMUF) is traded on OTC Market in USA. It is located in Grenzacherstrasse 487 and employs 228 people. The company currently falls under 'Small-Cap' category with current market capitalization of 775.28 M. Basilea Pharmaceutica AG has 10.83 M outstanding shares. BASILEA PHARMACEU has accumulated about 271.96 M in cash with 19.83 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.02.
Check Basilea Pharmaceutica Probability Of Bankruptcy

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 65.66%30 days 70.14  about 34.27%
Based on normal probability distribution, the odds of Basilea Pharmaceutica to move above current price in 30 days from now is about 34.27% (This Basilea Pharmaceutica AG probability density function shows the probability of Basilea Pharmaceutica Stock to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Blair William CoCommon Shares134.4 K15.9 M
View Basilea Pharmaceutica Diagnostics

Basilea Pharmaceutica AG Risk Profiles

Key Fundamentals

Basilea Pharmaceutica Against Markets

Current Ratings

Basilea Pharmaceutica 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 42% 
Equity ratings for Basilea Pharmaceutica AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Basilea Pharmaceutica AG, together with its subsidiaries, operates as an integrated biopharmaceutical company. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Basel, Switzerland. Basilea Pharmaceutica operates under Biotechnology classification in USA and traded on OTC Market. It employs 228 people. more
NameBasilea Pharmaceutica AG
CEORonald ScottView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressGrenzacherstrasse 487
ExchangeOTC Market
Contact Number41 61 606 11 11
CurrencyUSD - US Dollar

Diversify with Basilea Pharmaceutica AG

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Basilea Pharmaceutica AG to your portfolio


Basilea Pharmaceutica Corporate Directors
Thomas Rinderknecht Member of the Board of Directors, Ph.D
Daniel Lew Member of the Board of Directors
Domenico Scala Member of the Board of Directors
Check also Trending Equities. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.